PC Pharma PLC Reports Unaudited Earnings Results for the Second Quarter and Six Months Ended September 30, 2013
For the six months, the company reported revenue of LKR 202,326,949, loss before taxation of LKR 67,572,693 and net loss of LKR 67,572,693 or LKR 0.67 per basic share against revenue of LKR 317,721,174, profit before taxation of LKR 28,529,382 and net profit of LKR 20,541,155 or LKR 0.20 per basic share for the same period a year ago. Net cash from operating activities was LKR 47,595,527 against LKR 65,309,768 for the same period a year ago.